Table 1 Demographics of patients with and without prior TB infection who received adjuvant intravesical BCG therapy
Prior TB infection | Yes | No | P-value | ||
|---|---|---|---|---|---|
Numbers | 187 | (4.8%) | 3728 | (95.2%) | |
Sex | 0.025 | ||||
Female | 30 | (16.0%) | 860 | (23.1%) | |
Male | 157 | (84.0%) | 2868 | (76.9%) | |
Age | < 0.001 | ||||
< 50 years | 7 | (3.7%) | 371 | (10.0%) | |
50–64 years | 32 | (17.1%) | 1141 | (30.6%) | |
65–74 years | 62 | (33.2%) | 1133 | (30.4%) | |
≧75 years | 86 | (46.0%) | 1083 | (29.0%) | |
Disease recurrence | 38 | (20.3%) | 851 | (22.8%) | |
Times of instillation before disease recurrence | 6 | (1–9) | 6 | (1–48) | 0.551 |
Disease progression (cystectomy + radiotherapy) | 19 | (10.2%) | 477 | (12.8%) | |
Partial or radical cystectomy | 2 | (1.1%) | 94 | (2.5%) | |
Times of instillation before cystectomy | 9 | (6–12) | 6 | (1–21) | 0.281 |
Radiotherapy | 18 | (9.6%) | 413 | (11.1%) | |
Times of instillation before radiotherapy | 6 | (1–18) | 6 | (1–58) | 0.550 |
Severe urinary tract infection | 0 | (0.0%) | 4 | (0.1%) | 0.999 |
Total times of instillation within 3 months | 6 | (1–8) | 6 | (1–9) | 0.017* |